NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Prometheus Biosciences, Inc. (NASDAQ: RXDX) to Merck for $200.00 per share in cash is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results